- Home
- INFA vs RGEN Comparison
INFA vs RGEN Comparison
Compare INFA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFA
- RGEN
- Stock Information
- Founded
- INFA 1993
- RGEN 1981
- Country
- INFA United States
- RGEN United States
- Employees
- INFA N/A
- RGEN N/A
- Industry
- INFA EDP Services
- RGEN Medical/Dental Instruments
- Sector
- INFA Technology
- RGEN Health Care
- Exchange
- INFA Nasdaq
- RGEN Nasdaq
- Market Cap
- INFA 8.2B
- RGEN 7.6B
- IPO Year
- INFA 2021
- RGEN N/A
- Fundamental
- Price
- INFA $26.90
- RGEN $144.46
- Analyst Decision
- INFA Buy
- RGEN Buy
- Analyst Count
- INFA 12
- RGEN 12
- Target Price
- INFA $33.67
- RGEN $187.44
- AVG Volume (30 Days)
- INFA 2.3M
- RGEN 531.4K
- Earning Date
- INFA 02-12-2025
- RGEN 11-12-2024
- Dividend Yield
- INFA N/A
- RGEN N/A
- EPS Growth
- INFA N/A
- RGEN N/A
- EPS
- INFA 0.21
- RGEN N/A
- Revenue
- INFA $1,656,891,000.00
- RGEN $633,513,000.00
- Revenue This Year
- INFA $6.70
- RGEN $2.23
- Revenue Next Year
- INFA $6.99
- RGEN $10.07
- P/E Ratio
- INFA $126.22
- RGEN N/A
- Revenue Growth
- INFA 6.98
- RGEN N/A
- 52 Week Low
- INFA $22.08
- RGEN $113.50
- 52 Week High
- INFA $39.80
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- INFA 53.67
- RGEN 45.89
- Support Level
- INFA $25.84
- RGEN $143.91
- Resistance Level
- INFA $27.34
- RGEN $161.24
- Average True Range (ATR)
- INFA 0.96
- RGEN 6.16
- MACD
- INFA -0.04
- RGEN -0.96
- Stochastic Oscillator
- INFA 59.80
- RGEN 12.10
About INFA Informatica Inc.
Informatica Inc is a pioneered new category of software, the Intelligent Data Management Cloud, or IDMC. IDMC is an AI-powered platform that connects, manages, and unifies data across any multi-cloud, hybrid system, empowering enterprises to modernize and advance data strategies.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.